XML 165 R38.htm IDEA: XBRL DOCUMENT
v3.19.3.a.u2

Investments in and Advances to Unconsolidated Joint Ventures (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2019
Equity Method Investments and Joint Ventures [Abstract] |
Schedule of company owned interests in entities, accounted under equity method | The Company owns interests in the following entities that are accounted for under the equity method (dollars in thousands):
|  |  |  |  | Carrying Amount
|  |  |  |  | December 31,
Entity(1) |  | Property Count | Ownership % |  | 2019 |  | 2018
SWF SH JV(2) |  | 19 | 54 |  | $ | 428,258 |  |  | $ | — |
CCRC JV(3) |  | 15 | 49 |  | 325,830 |  |  | 365,764 |
U.K. JV(4) |  | — | 49 |  | — |  |  | 101,735 |
MBK JV |  | 4 | 50 |  | 33,415 |  |  | 35,435 |
Other SHOP JVs(5) |  | 5 | 41-90 |  | 26,876 |  |  | 25,493 |
Medical Office JVs(6) |  | 3 | 20-67 |  | 9,845 |  |  | 10,160 |
K&Y JVs(7) |  | 2 | 80 |  | 1,215 |  |  | 1,430 |
Advances to unconsolidated joint ventures, net |  |  |  |  | 76 |  |  | 71 |
|  |  |  |  | $ | 825,515 |  |  | $ | 540,088 |
_______________________________________
(1) | These entities are not consolidated because the Company does not control, through voting rights or other means, the joint ventures.
(2) | In December 2019, the Company formed the SWF SH JV with a sovereign wealth fund. See Note 4 for discussion of the formation of the SWF SH JV.
(3) | See Note 3 for discussion of the 2019 MTCA with Brookdale, including the pending acquisition of Brookdale’s interest in the CCRC JV.
(4) | See Note 4 for discussion of the formation of the U.K. JV in 2018 and subsequent sale of the Company’s equity method investment in 2019.
(5) | In June 2019, the Company acquired the outstanding equity interests in, and began consolidating, the Vintage Park JV (see Note 4). Remaining unconsolidated SHOP joint ventures (and the Company's ownership percentage) include: (i) Waldwick JV (85%); (ii) Otay Ranch JV (90%); (iii) MBK Development JV (50%); (iv) Discovery Naples JV (41%); and (v) Discovery Sarasota JV (47%). The Company’s investments in the Discovery Naples JV and the Discovery Sarasota JV are preferred equity investments earning a 10% per annum fixed-rate return.
(6) | Includes three unconsolidated medical office joint ventures (and the Company’s ownership percentage): (i) Ventures IV (20%); (ii) Ventures III (30%); and (iii) Suburban Properties, LLC (67%).
(7) | At December 31, 2019, includes one unconsolidated joint venture. In October 2019, the Company sold its interest in one of the K&Y joint ventures for $4 million. In January 2020, the Company sold its interest in the remaining K&Y joint venture for $12 million. At December 31, 2018, includes three unconsolidated joint ventures.
The following tables summarize combined financial information for the Company’s unconsolidated joint ventures (in thousands):
|  | December 31,
|  | 2019 |  | 2018
Real estate, net |  | $ | 2,278,743 |  |  | $ | 2,128,147 |
Other assets, net |  | 511,014 |  |  | 479,935 |
Total assets |  | $ | 2,789,757 |  |  | $ | 2,608,082 |
Mortgage and other debt |  | $ | 552,824 |  |  | $ | 827,622 |
Accounts payable and other |  | 591,498 |  |  | 655,177 |
Other partners’ capital |  | 756,359 |  |  | 515,791 |
Healthpeak Properties, Inc.'s capital |  | 889,076 |  |  | 609,492 |
Total liabilities and partners’ capital |  | $ | 2,789,757 |  |  | $ | 2,608,082 |
|  | Year Ended December 31,
|  | 2019 |  | 2018 |  | 2017
Total revenues |  | $ | 523,684 |  |  | $ | 642,724 |  |  | $ | 810,216 |
Total operating expense |  | (381,257 | ) |  | (492,784 | ) |  | (643,452 | )
Net income (loss) |  | (50,872 | ) |  | (43,704 | ) |  | (42,408 | )
Healthpeak Properties, Inc.’s share in earnings (losses) |  | (8,625 | ) |  | (2,594 | ) |  | 10,901 |
Fees earned by Healthpeak Properties, Inc. |  | 169 |  |  | 125 |  |  | 133 |
Distributions received by Healthpeak Properties, Inc. |  | 47,186 |  |  | 48,939 |  |  | 81,165 |

X
- References No definition available. + Details
Name: | us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 323 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571 + Details
Name: | us-gaap_EquityMethodInvestmentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration